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A number of Saccharomyces cerevisiae membranebound oxidoreductases were examined for potential
roles in microsomal fatty acid elongation, by assaying
heterologous elongating activities in individual deletion
mutants. One yeast gene, YBR159w, was identified as
being required for activity of both the Caenorhabditis
elegans elongase PEA1 (F56H11.4) and the Arabidopsis
thaliana elongase FAE1. Ybr159p shows some limited
homology to human steroid dehydrogenases and is a
member of the short-chain alcohol dehydrogenase superfamily. Disruption of YBR159w is not lethal, in contrast to previous reports, although the mutants are slow
growing and display high temperature sensitivity. Both
Ybr159p and an Arabidopsis homologue were shown to
restore heterologous elongase activities when expressed
in ybr159⌬ mutants. Biochemical characterization of microsomal preparations from ybr159⌬ cells revealed a primary perturbation in ␤-ketoacyl reduction, confirming
the assignment of YBR159w as encoding a component of
the microsomal elongase.

Unsaturated fatty acids are essential cellular constituents,
serving not only as structural components of membranes but
also as bioactive metabolites. One important class of these
lipids is collectively known as polyunsaturated fatty acids
(PUFAs)1; these are defined as fatty acids of 18 carbons or more
(C18⫹), which contain two or more double bonds (1). In mammals, 20 carbon (C20) PUFAs have been shown to be the biological precursors of a group of molecules called the eicosanoids, which includes the prostaglandins, leukotrienes, and
thromboxanes (2). The eicosanoids have roles in inflammation
responses as well as cardiac and reproductive function. This
obvious importance of PUFAs has resulted in considerable
interest in the characterization of their biosynthetic pathway
(3), and we have identified a new class of fatty acid desaturases
required for PUFA biosynthesis, which contain an N-terminally fused cytochrome b5 domain (4).
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More recently, we have also identified a component of the
PUFA fatty acyl-chain elongation system, which when heterologously expressed in yeast, directs the C2 elongation of the
C18 PUFA ␥-linolenic acid (18:3(n-6); GLA) to the C20 PUFA
di-homo-␥-linolenic acid (20:3(n-6)) (5). This component (Caenorhabditis elegans ORF F56H11.4, designated PEA1 for polyunsaturated fatty acid elongating activity (5, 6)) shows some
limited homology to the yeast ELO gene family, which have
been shown genetically to be required for the synthesis of
saturated medium and very long-chain fatty acids (7, 8). Although the precise biochemical function of the C. elegans
PUFA-elongating activity PEA1 and the polypeptides encoded
by the ELO genes remain to be elucidated, it is generally
considered that they serve as condensing enzymes (5, 6). The
steps in the biosynthetic pathway of C20 PUFAs are indicated
in a generalized scheme (Fig. 1), with the key step of C2 elongation of C18 substrates highlighted.
The biosynthesis of C20⫹ fatty acids has also been observed
in higher plants, although the elongated fatty acids are quite
distinct to those observed in mammals. Although C18 PUFAs
such as ␣-linolenic acid and linoleic acid accumulate to high
levels in plants, the presence of C20 PUFAs has not been
observed (1). However, some higher plants, most notably members of the Brassicas such as oil seed rape and Arabidopsis,
synthesize C20 and C22 monounsaturated fatty acids (MUFAs)
(9). These C20⫹ fatty acids are the product of (several cycles of)
C2 fatty acyl elongation of a monounsaturated C18 substrate,
oleic acid (18:1⌬9). The biosynthesis of higher plant C20/22
MUFAs has been shown to require a single gene, FAE1 (fatty
acid elongation), which encodes a putative condensing enzyme
(10). The Fae1p condensing enzyme displays specificity only for
saturated and monounsaturated fatty acids (9, 10). Importantly, although Fae1p shows some limited homology to analogous condensing enzymes such as chalcone and stilbene synthases, it displays no similarity to the Elo protein family;
conversely no homologues of Fae1p are present in yeast.
Fatty acid elongation is carried out by a microsomal “elongase,” which consists of four distinct enzymatic reactions (11).
In sequential order, these are a condensation reaction between
a CoA-esterified fatty acyl substrate and malonyl-CoA, ␤-keto
reduction, dehydration, and a final enoyl reduction. It has been
hypothesized that the specificity of any particular elongation
reaction is conferred through the selectivity of the first condensation step. Conversely it is believed that the three other components (two reductases and a dehydratase) are common to all
microsomal fatty acyl elongases and have no particular substrate specificity (11). This is given credence by the observation
that heterologous expression in yeast of the plant Fae1p condensing enzyme successfully reconstitutes a functional C20⫹
MUFA-specific elongase (9). Similarly, we have also observed
effective reconstitution of the PUFA-specific elongase (via by
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FIG. 1. Generalized pathway for the
biosynthesis of polyunsaturated fatty
acids. A generalized scheme of the enzymes responsible for aerobic desaturation
and elongation of fatty acids is shown. The
reaction directed by the polyunsaturated
fatty acid elongase PEA1, resulting in the
production of C20 PUFAs, is boxed. The
yeast S. cerevisiae does not synthesize
PUFAs, serving as a convenient host for
“gain-of-function” screening.

heterologous expression of the C. elegans Pea1p in yeast) (5),
even though yeast has no endogenous capacity for either of
these particular biosynthetic reactions.
We have hypothesized that these heterologous elongating
activities function by “hi-jacking” endogenous microsomal elongases, which in the case of yeast, are primarily synthesizing the
C20 –26 saturated fatty acid components of sphingolipids (5).
This results in the presumptive redirection of the three endogenous components (reductases and dehydratase) toward nonnative substrates. Until very recently, little was known about
the identity of these other three enzyme activities and their
precise contribution(s) to the activity and specificity of microsomal fatty acid elongases. Kohlwein et al. (12) characterized
the TSC13 gene, which is one of a number of genes identified in
a screen for temperature-sensitive (ts) mutants with defects in
sphingolipid synthesis (13). Mutants with ts alleles of TSC13
displayed phenotypes similar to the elo2⌬ and elo3⌬ mutants,
including the accumulation of high levels of long-chain bases,
the accumulation of ceramides with chain lengths of less than
26 carbons, and a deficiency in very long chain fatty acid
synthesis (12). Microsomal fatty acid elongation assays revealed that the tsc13 mutation caused the accumulation of
trans-2,3- and 3-hydroxy-acyl intermediates; these observations, taken together with the homology between Tsc13p and
steroid-5-␣-reductase, are consistent with the TSC13 gene encoding the enoyl-reductase component of the microsomal elongase. Furthermore, epitope-tagged Tsc13p was shown to coimmunoprecipitate with the presumptive condensing enzymes
Elo2p and Elo3p (12). Interestingly, a precise ER location for
Tsc13p, enriched at sites of vacuole-nuclear envelope interaction, was observed. TSC13 is essential, as is expected for a gene
encoding a non-redundant fatty acid elongating activity (12).
As part of our studies on microsomal fatty acid elongation,
we have sought to identify other enzymatic components of the
fatty acid elongase. To that end, we screened yeast knockout
mutants for loss-of-function of our heterologous PUFA elongating activity PEA1 (5). Using this approach we identified a
previously functionally uncharacterized gene required for the
reconstitution of heterologous elongase activity.
MATERIALS AND METHODS

Cloning of Putative ␤-Ketoacyl Reductases in a Yeast Expression
Vector—The Saccharomyces cerevisiae ORF encoded by YBR159w was
cloned by PCR into the pESC-TRP vector (Stratagene). A crude DNA
extract was prepared using the reference strain W303-1A. 1 ml of an
overnight culture in rich medium (YPD) was centrifuged at 3000 ⫻ g for
5 min at room temperature, and the cells were resuspended in 0.5 ml of
TE buffer (10 mM Tris, pH 8.0, mM EDTA). This suspension was boiled
for 10 min, and the extract was centrifuged at 10,000 ⫻ g for 5 min.
1 l of the supernatant was used for PCR amplification using primers
YBR159.for (5⬘-GCGGGATCCACCATGACTTTTATGCAACAGC-3⬘)
and YBR159.rev (5⬘-GCGGGTACCCTATTCCTTTTTAACCGTCT TGC3⬘). The amplified sequence was then restricted using BamHI and KpnI
(underlined in the forward and reverse primers, respectively), purified
using the Qiagen PCR purification kit, and ligated into BamHI/KpnIcut pESC-TRP plasmid vector (Stratagene). An Arabidopsis thaliana
expressed sequence tag (GenBankTM accession number: AA10E08;

kindly provided by Prof. H. J. Bohnert, University of Arizona) derived
from gene F12A21.31 was used as template DNA for PCR amplification
using primers At159.for (5⬘-GCGGGATCCACCATGGAGATCTGCACTTACTTC-3⬘) and At159.rev (5⬘-GCGCTCGAGTCATTCTTTCTTCATGGAGTC-3⬘). The amplified sequence was then restricted using BamHI
and XhoI (underlined in the forward and reverse primers, respectively)
and cloned into BamHI/XhoI-cut pESC-TRP as described above.
Functional Characterization in Yeast—ORFs encoding putative
␤-ketoacyl-reductase activities and elongase or desaturase constructs
were introduced in Saccharomyces cerevisiae using a lithium acetatebased method (14). Expression of the transgenes was induced by addition of 2% (w/v) galactose in the presence or absence of exogenously
supplied fatty acid substrates as described previously (15). The mutant
strain used in this study was CEN.RO16; Mat a/␣; ura3–52/ura3–52;
his3⌬1/his3⌬1;
leu2–3_112/leu2–3_112;
trp1–289/trp1–289;
ybr159⌬::HIS3/YBR159w, obtained from European Saccharomyces
cerevisiae Archive for Functional Analysis (EUROSCARF) (available at
www.uni-frankfurt.de/fb15/mikro/euroscarf/index.html). This strain
was transformed with a pYES2 construct containing the C. elegans
PUFA elongating activity PEA1 (F56H11.4) and sporulated in SPM
liquid media as described previously (16). After sporulation, asci were
digested with ␤-glucuronidase (Sigma Chemical Co.), and the tetrads
were dissected using light microscopy and a micromanipulator as described (17). Separated ascospores were grown on YPD for up to 2 weeks
at 22 °C, and the mating type of each haploid colony tested using two
yeast strains, a sst1 and ␣ sst2 (18). “Wild type” (Mat a or ␣; ura3–52;
his3⌬1; leu2–3_112; trp1–289) and mutant spores (Mat a or ␣; ura3–52;
his3⌬1; leu2–3_112; trp1–289; ybr159⌬::HIS3) were identified by
replica plating on synthetic dextrose medium lacking histidine. This
was also confirmed by PCR using primers 159_prom.for (5⬘-CGGATTTGGAAGTCCTTTATAG-3⬘) and 5⬘_his3.rev (5⬘-CGCTTTACTAGGGCTTTCTGC-3⬘). Wild type and mutant spore colonies containing the
PUFAs-elongase construct in pYES2 were selected by replica plating on
synthetic dextrose medium lacking uracil.
Fatty Acid Analysis—Total fatty acids extracted from yeast cultures
were analyzed by gas chromatography (GC) of methyl ester derivatives.
Lipids were extracted and transmethylated with methanolic HCl. Fatty
acid methyl esters were analyzed as described before (19).
GC-MS Analysis—Induced peaks were characterized using GC-MS
(Kratos Analytical Instruments MS80RFA) operating at an ionization
voltage of 70 eV with a scan range 40 –500 Da and as described before
(19).
Elongase Activity Assays—Microsomes were prepared from the wild
type or ybr159⌬ mutant cells as has been previously described (20).
Total elongase activity was measured in a volume of 200 l containing
50 mM Tris, pH 7.5, 1 mM MgCl2, 150 M Triton X-100, 1 mM NADPH,
1 mM NADH, 10 mM ␤-mercaptoethanol, 40 M palmitoyl-CoA, 60 M
2[14C]malonyl-CoA (0.05 Ci/ml) at 37 °C. The reaction was initiated by
the addition of 0.4 mg of microsomal protein. Protein concentrations
were determined using the Bio-Rad protein assay reagent (Bio-Rad
Laboratories). For assays of only the condensing activity, the NADPH
and NADH were omitted. At various times (0.2, 1, or 5 min) the reaction
was terminated by adding 200 l of 5 M KOH/10% MeOH and heating
at 80 °C for 1 h. Following addition of 200 l of 10 N H2SO4, fatty acids
were recovered by two 1.5-ml extractions into hexane. The extracted
fatty acids were resolved by silica gel TLC using hexane:diethyl ether:
acetic acid (30:70:1) as the developing solvent and detected and quantified using a PhosphorImager SI (Molecular Dynamics, Inc.).
RESULTS

In an attempt to identify genes or genes that encode the
␤-keto-reductase of the microsomal elongase, we searched the
complete genome sequence of the yeast S. cerevisiae (predicted
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TABLE I
Yeast oxidoreductases identified as candidate components of the microsomal elongase
YBR159w was previously reported as being essential, although results obtained in this study indicate that ybr159⌬ mutant cells are actually
viable. The activity of the heterologous elongating activity PEA1 in deletion mutant strains is indicated.
Gene name/synonyms

YBR159w
YBR265w/TSC10
YMR226c
YIR036c
YIR035c
YIL124w/AYR1
YDL114w
YLR426w
YML131w
YBR046c/ZTA1
a

Function/similarity

Null mutant phenotype

17␤-Hydroxysteroid dehydrogenase
3-Ketosphinganine reductase
Short-chain alcohol dehydrogenasea
7␣-Hydroxysteroid dehydrogenasea
11␤-Corticosteroid dehydrogenasea
1-Acyl-dihydroxyacetone phosphate reductase
Short-chain alcohol dehydrogenasea
3-Oxoacyl-ACP reductase/alcohol dehydrogenasea
NAD-dependent oxidoreductasea
Quinone oxidoreductase
a

Lethal/reduced viability
Lethal in the absence of phytosphinganine
Viable
Viable
Viable
Viable
Viable
Viable
Viable
Viable

PUFA elongation

No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

ORFs with unassigned biochemical function but displaying significant similarity to functionally characterized activities.

to encode between 5000 and 6000 polypeptides) (21) for protein
sequences likely to encode oxidoreductases. This was carried
out either on a homology basis to known oxidoreductases or via
the presence of the diagnostic NADH binding motif (22). Because this generated over 200 candidates, the search was refined to exclude proteins already clearly functionally characterized, as well as cytosolic oxidoreductases. By excluding
predicted ORFs, which lacked a canonical dilysine ER retention motif, the search was further refined to identify predicted
oxidoreductases likely to have a transmembrane topology and
to be located in the ER. This approach allowed us to consider a
small number (⬃10) of genes for functional characterization as
potential microsomal fatty acyl elongase components (listed in
Table I). A number of these selected oxidoreductases ORFs had
previously been shown by high throughput deletion analysis to
be non-essential for viability. Yeast mutants in which the nonessential candidate genes were disrupted were assayed for any
loss of ability to carry out heterologous PUFA elongation. Thus,
a galactose-inducible, URA3-marked plasmid carrying the C.
elegans PEA1 PUFA elongating activity (5) was transformed
into these mutant strains, and the transformed yeast cells were
assayed for their ability to direct the C2 elongation of GLA,
forming the basis of a “loss-of-function” screen.
Characterization for loss-of-function in haploid knockout
mutants of the eight non-essential oxidoreductases (Table I)
revealed no alteration in their ability to reconstitute the heterologous PUFA elongase and redirect the elongation of C18
PUFAs. Although the synthesis of very long-chain fatty acids is
essential for yeast cell viability (8), previous directed ethyl
methanesulfonate (EMS) mutant screens for defects in fatty
acid elongation only identified the ELO1 gene as a potential
elongase component, implying that other elongase genes are
either essential or display functional redundancy (7, 8, 23). To
address the possibility that the (annotated as) essential gene
YBR159w encoded an oxidoreductase component of the microsomal elongase, a diploid yeast strain heterozygous for disruption of YBR159w was transformed with a plasmid containing
the PEA1 ORF. Following sporulation and tetrad dissection,
the spores were allowed to germinate on YPD media. Using this
approach, we observed that the ybr159⌬ haploid deletion was
in fact viable, although PCR confirmed the insertional disruption of this oxidoreductase ORF in mutant haploid cells (data
not shown). When compared with wild type spores isolated
from the same tetrad, spores containing the disrupted gene
showed a very reduced growth rate, with small colonies appearing usually only after 10 days of incubation at 22 °C.
An initial study described deletion of YBR159w (in strain
ENY.MR17) as resulting in poor growth (only at low tempera-

tures) with a pseudo-hyphal phenotype (24), although in a
subsequent study it was reported that YBR159w was an essential gene in the CEN.PK2 background (25). In our current
study, we used the same parental diploid heterozygote as used
in the latter study (CEN.PK2 strain background), although
after sporulation the haploid ybr159⌬ mutants were viable
even at 30 °C. Indeed, although it took about 10 days for mutant spores to germinate and to form a colony after meiosis (see
above), ybr159⌬ cells are able to grow at 30 °C in rich medium
(in the absence of fatty acid supplements) but at a slower rate
than wild type (Fig. 2). Interestingly, cultivating ybr159⌬ cells
in a media supplemented with medium and long-chain fatty
acids did not improve the growth rate (data not shown). However, we observed that the ybr159⌬ mutant displayed temperature sensitivity when transferred to 37 °C. We also examined
the phenotypic appearance of the CEN.PK strain ybr159⌬ mutant cells and observed the previously reported (for strain
ENY.MR17) pseudo-hyphal growth (24). However, genetic
analysis indicates that this phenotype is unlinked to the
ybr159⌬ mutation.2
The Oxidoreductase Ybr159p Is Specifically Required for Heterologous Elongation Activity in S. cerevisiae—The ability of
the heterologous elongating activity Pea1p to function in the
ybr159⌬ deletion was tested by galactose induction as described above. Wild type haploid colonies displayed PUFA elongating activity resulting in the conversion of 18:3(n-6) (GLA)
into 20:3(n-6) (di-homo-␥-linolenic acid), whereas deletion mutant haploids completely failed to elongate heterologous C18
PUFAs (Fig. 3, top panel). We tested the galactose inducibility
of other pYES2-directed enzyme activities in this haploid
knockout strain to assess the possibility of pleiotropic effects on
either galactose uptake or lipid metabolism. However, when
two other (heterologous) enzymes of the PUFA biosynthetic
pathway (borage ⌬6-desaturase (19), C. elegans 3-desaturase
(26); see also Fig. 1) were tested in this mutant background,
they displayed unaltered activities when compared with wild
type yeast (Table II). Northern blot analysis of mutant cells
expressing the heterologous elongase revealed no alteration in
transcript abundance when compared with wild type (data not
shown). Thus, deletion of YBR159w had a specific effect on the
activity of the heterologous PUFA elongase reconstituted by
expression of PEA1. This was given additional weight by our
observation that YBR159w was also required for the activity of
the Arabidopsis microsomal elongase condensing enzyme
FAE1 (10); expression of Fae1p in ybr159⌬ haploid strains
failed to accumulate C20⫹ MUFAs (Fig. 3, bottom panel).
Several ORFs Related to YBR159w Are Present in S. cerevisiae and in Other Yeast, Plant, and Animal Genomes—Exam2

T. Dunn, unpublished observations.
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FIG. 2. Wild type and ybr159⌬ mutant cells display different
growth rates in YPD at 30 °C. Liquid cultures in YPD were inoculated with wild type and mutant cells, picked from YPD plates conserved at 4 °C, and incubated for up to 72 h at 30 °C. Cell growth was
monitored by measuring the optical density of the cultures at 600 nm.

ination of the deduced amino acid sequence encoded by
YBR159w indicated that the predicted polypeptide (of 347
amino acids) showed some similarity to human estradiol-17␤hydroxysteroid dehydrogenase (32% similarity). For this reason, it has recently been suggested that the enzyme encoded by
YBR159w could be responsible for steroid dehydrogenase activities observed in vitro in yeast extracts (27). However, no
sequences homologous to YBR159w could be detected by PCR
and Northern hybridization in the mesophilic yeasts Candida
tropicalis and Cryptococcus tsukubaensis even though steroid
dehydrogenase activity was observed. These observations have
led the authors to speculate that the Ybr159p oxidoreductase
does not function as a steroid dehydrogenase (27); this is in
agreement with our present study. Presumptive orthologues of
Ybr159p are also present in fission yeast (43% similarity),
Drosophila melanogaster (34% similarity), C. elegans (30% similarity), and Arabidopsis (30% similarity) (Fig. 4A). Not only do
all these sequences contain the diagnostic NADH binding motif
(22), they also share a number of conserved residues, in particular the catalytically essential (for estradiol-17␤-hydroxysteroid dehydrogenase) motif Y-X3-K (28). There are also canonical dilysine ER retention motifs present in both Ybr159p and
the Arabidopsis orthologue, consistent with these proteins’ predicted multiple (presumptively endoplasmic reticulum) membrane-spanning topology. When the polypeptide sequence of
Ybr159p was used to search the complete yeast genome sequence, several related, but distinct, ORFs were detected.
These included Ymr226p (which shows some homology to insect short-chain alcohol dehydrogenase; 33% similar), Ayr1p
(1-acyl-dihydroxyacetone-phosphate reductase (29); 24% similar), and Yir036p (which shows homology to 7␣-hydroxysteroid
dehydrogenase; 23%) (Fig. 4B). Individual deletion analysis of
these three ORFs had previously indicated that none of these
genes encode essential proteins. More importantly, individual
deletion of any of these ORFs (YMR226c, AYR1/YIL124w,
YIR036c) did not alter the activity of the heterologous PUFA
elongase PEA1 as determined by our loss-of-function assay
(data not shown; see also Table I for summary).
ybr159⌬ Mutants Can Be Complemented by a Homologous
ORF from A. thaliana—Further confirmation of the role of
Ybr159p in heterologous microsomal elongation activity was
obtained by rescue of either Pea1p or Fae1p (PUFA or MUFA,
respectively) elongating activities by episomal co-expression of
either the wild type YBR159w ORF from S. cerevisiae or a

presumptive A. thaliana homologue ORF (F12A21.31). In
ybr159⌬ cells, the galactose-induced co-expression of YBR159w
with PEA1 resulted in restoration of 72% of C18 PUFA elongating activity, respectively, when compared with the activity
of the same enzymes in wild type cells (Table III). When the
presumptive Arabidopsis orthologue F12A21.31 was co-expressed instead of YBR159w, this resulted in a very similar
restoration of PUFA elongation (Table III); for that reason we
hereafter refer to F12A21.31 as At-YBR159. Similarly, co-expression of YBR159w with FAE1 in ybr159⌬ cells resulted in a
52% restoration of C18 MUFA elongation, whereas co-expression with At-YBR159 resulted in restoration of 42% of FAE1
activity, compared with wild type cells (Table IV).
Interestingly, episomal galactose-induced overexpression of
YBR159w in wild type spore colonies (derived from the same
tetrads that had yielded the ybr159⌬ haploids) resulted in
moderate increases in both PEA1 (PUFA) and FAE1 (MUFA)
heterologous elongation activities, compared with the expression of these elongating activities in wild type cells (Tables III
and IV). This suggests that, in contrast with native elongase
systems, the condensation reaction may not be the only ratelimiting activity for heterologous elongation in yeast. Co-expression of the same elongating activities with At-YBR159 in
wild type yeast resulted in almost equivalent results, again
demonstrating the functional equivalence of the Arabidopsis
protein.
ybr159⌬ Mutant Cells Have Reduced Endogenous Fatty Acid
Elongation Activity—ybr159p clearly plays a role in the fatty
acid elongation mediated by the heterologously expressed
Fae1p and Pea1p activities in yeast. Based on its homology to
the oxidoreductases, it was considered a good candidate for a
␤-keto-reductase, reducing the 3-keto intermediate formed by
the condensing activity during each cycle of fatty acid elongation. To address how elongation is affected in the ybr159⌬
mutant cells, microsomes were prepared and assayed for elongase activity in vitro. The elongation cycle initiates with the
condensation of malonyl-CoA with an acyl-CoA (e.g. palmitoylCoA) to form a 3-ketoacyl-CoA intermediate. Omitting pyridine
nucleotide from the assay mix prevents the reduction of the
3-ketoacyl-CoA intermediate and thereby allows the first step
of elongation to be measured (12). The condensation activity
measured over a time course of 5 min was very similar whether
wild type or ybr159⌬ microsomes were used for the assay (Fig.
5, compare lanes 4 – 6 and 10 –12). However, when the time
course of the overall elongation reaction (with NADH/NADPH
included) was conducted and the products were analyzed by
TLC using conditions that resolved the four intermediates of
fatty acid elongation, differences between the wild type and
ybr159⌬ mutant were apparent. The only intermediate seen in
the elongation catalyzed by the wild type microsomes was a
small amount of 3-hydroxy intermediate in the 5-min time
point (Fig. 5, lane 3) under conditions where a large amount of
fully elongated product accumulated. In contrast, a large
amount of the 3-keto intermediate accumulated and the formation of the fully elongated product were greatly delayed during
the elongation catalyzed by the ybr159⌬ mutant microsomes
(Fig. 5, lanes 8 and 9). Based on the homology of Ybr159p to
oxidoreductases, it may directly catalyze the reduction of the
3-keto intermediate that is formed in each cycle of elongation.
However, in addition to the 3-keto intermediate, elevated
amounts of the 3-hydroxy intermediate also accumulated (compare the difference in the ratio of this intermediate to the fully
elongated product in the mutant to that in the wild type, Fig. 5,
lane 3 versus lane 9). Although the accumulation of the 3-keto
intermediate of elongation would be consistent with Ybr159p
functioning as a ␤-keto-reductase, it is not clear why the 3-hy-
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FIG. 3. Analysis of fatty acid elongation activity in ybr159⌬ yeast. Chromatograms of fatty acid methyl esters
prepared form wild type (WT) and mutant
(ybr159⌬) yeast expressing either C. elegans PUFA elongating activity PEA1
(top panel) or A. thaliana MUFA elongating activity FAE1 (bottom panel). ␥-Linolenic acid (18:3 ⌬6,9,12) was supplied as an
exogenous substrate to cells expressing
PEA1. Fatty acid elongation was detected
by flame ionization, with peak identification by subsequent GC-MS. In wild type
cells the expression of PEA1 or FAE1 resulted in the production of 18-, 20-, and
22-carbon elongation products (peaks indicated by arrows). In ybr159⌬ cells elongation activity was completely absent. Asterisk, the expression of FAE1 in wild type
yeast cells also resulted in the accumulation of 14-carbon-saturated and monounsaturated fatty acids.

TABLE II
Expression of desaturase genes in ybr159⌬ yeast
Fatty acid composition of ybr159⌬ or wild type yeast transformed with either the borage ⌬6-fatty acid desaturase (Bor⌬6) or the C. elegans
3-fatty acid desaturase (EAT1) cloned into the pYES2 vector (Invitrogen) under the control of the GAL1 promoter. Linoleic acid (C18:2⌬9,12) was
added to the cultures before induction with galactose. Induced cultures were incubated at 22 °C for 48 h, and the fatty acid composition was
analysed as described under “Materials and Methods.” All values are expressed as mol% of total fatty acids. Standard deviations are also given.
The percent desaturation of substrates was calculated using the following formula: Product/(substrate ⫹ product) ⫻ 100, with substrate and
product being the mol% of LA and ALA or GLA, respectively.
Bor⌬6 (⫹LA)

Episomal gene
Haploid genotype

ybr159⌬

FAT1 (⫹LA)
WT

ybr159⌬

WT

14.1 ⫾ 0.6
48.2 ⫾ 2.4

16.2 ⫾ 0.7
43.8 ⫾ 2.3

3.1 ⫾ 0.4
17.1 ⫾ 1.2
16.1 ⫾ 1.5
1.4 ⫾ 0.5

4.0 ⫾ 0.3
14.1 ⫾ 0.7
19.7 ⫾ 0.9
2.2 ⫾ 0.7

8.0

10.0

mol%

Fatty acid
16:0
16:1⌬9
16:2⌬6,12
18:0
18:1⌬9
18:2⌬9,12 (LA)
␣18:3⌬9,12,15 (ALA)
␥18:3⌬6,9,12 (GLA)

14.5 ⫾ 0.9
43.5 ⫾ 3.7
2.9 ⫾ 1.2
4.2 ⫾ 1.0
15.8 ⫾ 1.9
13.9 ⫾ 2.5

15.6 ⫾ 1.2
38.8 ⫾ 2.6
3.1 ⫾ 1.1
4.2 ⫾ 0.7
13.5 ⫾ 1.3
17.4 ⫾ 2.6

5.2 ⫾ 2.2

7.4 ⫾ 1.7
%

% Desaturation
16:1⌬9
18:2⌬9,12 (LA)

6
27

droxy intermediate would also accumulate in the mutant (see
“Discussion” for possible explanations). In addition, although
Ybr159p is not essential for viability, very long chain fatty
acids are. Therefore, if Ybr159p is a ␤-keto-reductase activity
that functions in elongation, there must be functionally redundant activity. This is consistent with the non-lethality of the
disruption of this gene.
DISCUSSION

In this study, we report the identification of a yeast gene
required for the reconstitution of a heterologous microsomal
fatty acid elongase. This gene, identified as YBR159w is pre-

7.5
29.8

dicted to encode an integral membrane protein, most likely
located in the ER. The encoded protein shows some limited
homology to mammalian steroid dehydrogenases, most notably
estradiol-17␤-hydroxysteroid dehydrogenase, and is a member
of the short-chain dehydrogenase superfamily (Sanger Protein
Family Data base ID: Pfam00106). Interestingly, the Arabidopsis homologue of Ybr159p functionally characterized by us in
this study was previous annotated by Xu et al. (30) as being an
orthologue of the maize Glossy8 gene. Transposon-induced mutations in this maize gene result in defects in the synthesis of
the cuticular waxes deposited on the outer epidermis of the

11486

Microsomal Elongase ␤-Keto-reductases

FIG. 4. A, sequence comparisons of S. cerevisiae gene product Ybr159p and homologues from other species. SPAC4G9.15: putative short-chain
alcohol dehydrogenase from S. pombe (CAA93565); C56G2.6: possible estradiol-17␤-hydroxysteroid dehydrogenase from C. elegans (AAA64333);
CG1444: putative oxidoreductase from D. melanogaster (BI370369); F12A21.31: putative ␤-ketoacyl-reductase from A. thaliana (AF361844);
HSD17B3: 17␤-hydroxysteroid dehydrogenase from Homo sapiens (NP_000188). B, sequence comparisons of Ybr159p and related sequences from
S. cerevisiae: Ymr226p (CAA90197); Yil124p (CAA86868); Yir036p (CAA86196). Potential membrane-spanning regions were identified using the
TopPred2 topology prediction server (available at bioweb.pasteur.fr/seqanal/interfaces/toppred.html) and are indicated by black lines. The putative
NADH binding motif (G(X)3GXG(X)3A(X)3A(X)2G) and the essential catalytic motif (Y(X)3K) are also indicated.
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TABLE III
Rescue of PUFA elongation activity in ybr159⌬ yeast
Fatty acid composition of mutant (ybr159⌬) or wild type (WT) yeast coexpressing PEA1 (cloned into pYES2) and either S. cerevisiae ORF
YBR159w or AtYBR159, an homologue ORF from A. thaliana (both cloned into pESC-TRP). All episomal gene constructs were under the control
of the GAL1 promoter. ␥-Linolenic acid (18:3 ⌬6,9,12) was supplied as exogenous substrate and the fatty acid composition of induced yeast was
analyzed as described in Table 2. The percent elongation of substrates was calculated using the following formula: Product /(substrate ⫹ product) ⫻
100, with substrate and product being the mol% of 16:1⌬9 and 18:1⌬11 or of GLA and DHGLA, respectively.
Episomal gene 1

PEA1 (⫹GLA)

Episomal gene 2
Haploid genotype

⫺

⫹ YBR159

ybr159⌬

WT

⫹ AtYBR159

ybr159⌬

WT

ybr159⌬

WT

14.3 ⫾ 0.1
26.7 ⫾ 0.6
3.8 ⫾ 0.1
21.2 ⫾ 0.1
5.9 ⫾ 0.2
9.8 ⫾ 0.2
17.9 ⫾ 0.5

12.5 ⫾ 1.5
49.3 ⫾ 1.0
2.6 ⫾ 0.2
23.8 ⫾ 2.1
6.0 ⫾ 0.4
3.6 ⫾ 0.6
2.2 ⫾ 1.0

16.3 ⫾ 4.4
35.6 ⫾ 3.4
3.5 ⫾ 0.8
23.0 ⫾ 4.3
7.5 ⫾ 3.5
7.6 ⫾ 3.0
6.5 ⫾ 2.5

18
65

11
38

17.4
46

mol%

Fatty acid
16:0
16:1⌬9
18:0
18:1⌬9
18:1⌬11 (Vac)
␥18:3⌬6,9,12 (GLA)
20:3⌬8,11,14 (DHGLA)

14.2 ⫾ 1.0
50.3 ⫾ 5.2
3.1 ⫾ 0.6
27.1 ⫾ 3.5

15.4 ⫾ 3.2
39.5 ⫾ 5.1
3.3 ⫾ 0.8
27.8 ⫾ 6.3
6.2 ⫾ 2.5
3.5 ⫾ 2.0
4.3 ⫾ 1.8

5.3 ⫾ 1.2

11.3 ⫾ 0.6
43.9 ⫾ 2.1
3.7 ⫾ 0.3
26.4 ⫾ 4.2
5.8 ⫾ 1.1
5.4 ⫾ 0.5
3.5 ⫾ 0.5
%

% Elongation
16:1⌬9
␥18:3⌬6,9,12 (GLA)

13.5
55

11.7
40

TABLE IV
Rescue of MUFA elongation activity in ybr159⌬ yeast
Fatty acid composition of mutant (ybr159⌬) or wild type (WT) yeast coexpressing FAE1 and either S. cerevisiae ORF YBR159w or A. thaliana
ORF AtYBR159. Fatty acid analysis was performed as described in Table 2. The percent elongation of substrates was calculated using either the
formula: Product /(substrate ⫹ product) ⫻ 100, with substrate and product being the mol% of 20:0 and 22:0 or of 20:1⌬11 and 22:1⌬13, respectively;
or the formula: (Product1 ⫹ product2) /(substrate ⫹ product1 ⫹ product2) ⫻ 100, with substrate product1 and product2 being the mol% percentage
of 18:0, 20:0, and 22:0 or of 18:1⌬9, 20:1⌬11, and 22:1⌬13, respectively.
FAE1

Episomal gene 1
Episomal gene 2
Haploid genotype

⫺
ybr159⌬

⫹ YBR159
WT

ybr159⌬

⫹ AtYBR159
WT

ybr159⌬

WT

7.7 ⫾ 0.4
65.3 ⫾ 0.5
2.2 ⫾ 0.1
14.8 ⫾ 0.7
2.4 ⫾ 0.1
5.7 ⫾ 0.1
1.3 ⫾ 0.2
0.6 ⫾ 0.1

11.0 ⫾ 0.7
70.2 ⫾ 2.4
2.4 ⫾ 0.1
14.4 ⫾ 0.9
0.6 ⫾ 0.1
1.1 ⫾ 0.2
0.2 ⫾ 0.1
0.1 ⫾ 0.0

9.6 ⫾ 0.6
63.9 ⫾ 0.8
2.6 ⫾ 0.1
14.7 ⫾ 0.2
2.0 ⫾ 0.1
5.7 ⫾ 0.5
1.0 ⫾ 0.1
0.5 ⫾ 0.1

62.7
29.9
35.1
10.0

25.0
7.7
25.0
8.3

53.6
29.7
33.0
8.0

mol%

Fatty acid
16:0
16:1⌬9
18:0
18:1⌬9
20:0
20:1⌬11
22:0
22:1⌬13

13.4 ⫾ 0.5
56.9 ⫾ 4.8
3.3 ⫾ 0.2
26.4 ⫾ 4.1

8.5 ⫾ 0.9
62.5 ⫾ 1.3
2.5 ⫾ 0.4
15.4 ⫾ 1.3
2.5 ⫾ 0.5
5.7 ⫾ 0.7
1.4 ⫾ 0.2
1.1 ⫾ 0.2

12.2 ⫾ 0.7
69.5 ⫾ 2.1
2.4 ⫾ 0.6
13.0 ⫾ 1.1
0.7 ⫾ 0.1
1.6 ⫾ 0.2
0.4 ⫾ 0.1
0.2 ⫾ 0.1
%

% elongation
18:0
18:1⌬9
20:0
20:1⌬11

60.0
30.6
35.8
16.2

plant’s cells, giving the mutant plant a characteristic “glossy”
appearance (30). The maize glossy8 locus was cloned via transposon inactivation tagging and, although not characterized
biochemically, was hypothesized (on the basis of homology to
other dehydrogenases) to encode a ␤-ketoacyl-reductase (30).
Homozygous glossy8 maize mutants display decreased levels of
C24⫹ components of wax esters but are viable, indicating either
gene redundancy or the presence of distinct elongases for fatty
acid and wax synthesis. A partial-length cDNA clone from
Arabidopsis (GenBankTM accession number U89512) was also
identified in that study as being a likely orthologue of maize
Glossy8. That Arabidopsis transcript is derived from
F12A21.31, the gene identified by us as encoding a functional
homologue of the yeast microsomal ␤-keto-reductase Ybr159p.
Based on the data presented in this paper, we believe it is now
possible to assign the function of ␤-keto-reductase to the maize
Glossy8 locus.
Previous assessments of the requirement of YBR159w for

31.4
12.2
36.4
11.1

yeast viability yielded slightly contradictory data, with the
gene being described as essential in the CEN.PK2 background
but viable at reduced temperatures in the ENY.MR17 background. One explanation for the discrepancy in previous viability data may be explained by our observation of a long “lag”
period in the initial growth of newly isolated haploid mutants.
This initial slow growth may be related to some form of adaptive response to the loss of this microsomal elongase component.
After this “adaptation” the mutant spore colonies formed are
viable in the absence of fatty acid supplement, although growing at a much slower rate than wild type cells (Fig. 2). In that
respect it may be analogous the adaptation of srp54⌬ null
mutants, in which the loss of a component of the ER protein targeting machinery is bypassed through an adaptive
mechanism (31).
Mutagenic approaches to the identification of genes involved
in fatty acid elongation have previously only identified one
component, Elo1p, that is believed to be a condensing enzyme.
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credence to the hypothesis that the microsomal elongase is likely
to function as a large multimeric protein complex. In that respect,
proximal physical interactions between other microsomal elongase components such as Tsc13p and Elo2p/Elo3p have previously been demonstrated (12).
Conclusions—In this study we have used a “loss-of-heterologous-function” screen to genetically identify a component of
the microsomal fatty acid elongase. Biochemical characterization confirms the identification of the encoded polypeptide as
the ␤-keto-reductase. As such, this is the first report of the
identification of a gene encoding this microsomal enzyme.
Moreover, overexpression of the ␤-keto-reductase can result in
enhanced activity of (heterologous) elongases, challenging the
concept that the condensing enzyme is the rate-limiting step in
fatty acyl elongation.

FIG. 5. ybr159⌬ cells are deficient in fatty acid-chain elongation. Fatty acid elongation activity in wild type (lanes 1– 6) and
ybr159⌬ mutant (lanes 7–12) microsomes was compared using palmitoyl-CoA and radiolabeled malonyl-CoA as substrates. The assays were
performed in the absence of NADH/NADPH (lanes 4 – 6 and 10 –12) to
measure condensation activity and in the presence of NADH/NADPH
(lanes 1–3 and 7–9) to measure overall elongation activity. The reactions were stopped at the indicated times, and the fatty acids were
extracted and separated by TLC. The positions where the 3-ketostearate (3-Keto), 3-hydroxystearate (3-Hydroxy), and stearate standards
(included on the TLC and visualized by charring after exposure to the
PhosphorImager screens) migrated are indicated.

The failure to recover mutants in the other enzymatic reactions
that comprise the elongase system have been interpreted as
indicating either functional redundancy (as exemplified in the
case of the ELO2/3 genes) or lethality upon disruption. The
essential nature of the activity of the microsomal elongase for
yeast cell viability is clear from the synthetic lethality of
elo2elo3 mutants, as well as the requirement for a functional
copy of the TSC13 gene, which encodes the enoyl-reductase.
Our observation that YBR159w, a non-essential gene, is required for microsomal elongase activity is intriguing, especially
because of the lack of (functionally redundant) candidate homologues in the yeast genome. It is also clear that the lethality (or
not) on the loss of YBR159w is strain-dependent; our current
studies in the CEN.PK2 background indicate the viability of
ybr159⌬ mutants. Although there are no obvious homologues of
Ybr159p, it is possible that related, ER co-located oxidoreductases (i.e. paralogues of Ybr159p) are capable of (inefficiently) metabolizing 3-ketoacyl-CoA intermediates. This could explain the
viability of the ybr159⌬ mutant as well as the observed pronounced reduction (but not ablation) in elongase activity.
The experiments presented here suggest that Ybr159p is the
␤-keto-reductase activity of the microsomal fatty acid elongating
system. Consistent with this proposal, the in vitro elongation
assays reveal an accumulation of the 3-keto-fatty acyl elongation
intermediate. The accumulation of 3-hydroxacyl-CoA intermediates in the flux through the elongase of ybr159⌬ is equally intriguing. This could be due to a perturbation of the physical
interactions between the various distinct enzymatic components
as a result of the loss of Ybr159p. As such, this would give further
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